Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ravelli

Showing results (191-200 of 341) with videos related to

Pageof 35
Sort By:
Annals of the Rheumatic Diseases|December 19, 2013
Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity scoreAlessandro Consolaro, Nicolino Ruperto, Giulia Bracciolini, et al.
Annals of the Rheumatic Diseases|June 15, 2016
Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritisClaudia Bracaglia, Kathy de Graaf, Denise Pires Marafon, et al.
Journal of Pediatric Hematology/Oncology|February 24, 2021
Underlying CTLA4 Deficiency in a Patient With Juvenile Idiopathic Arthritis and Autoimmune Lymphoproliferative Syndrome Features Successfully Treated With Abatacept-A Case ReportMarta Mazzoni, Gianluca Dell'Orso, Alice Grossi, et al.
Arthritis and Rheumatism|November 13, 2002
Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositisMargherita Massa, Nick Costouros, Federica Mazzoli, et al.
Arthritis Research & Therapy|September 11, 2020
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trialsClara Malattia, Nicolino Ruperto, Silvia Pederzoli, et al.
Rheumatology (Oxford, England)|July 21, 2019
Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent feversRiccardo Papa, Marta Rusmini, Stefano Volpi, et al.
Rheumatology (Oxford, England)|August 15, 2019
Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent feversRiccardo Papa, Marta Rusmini, Stefano Volpi, et al.
RMD Open|March 8, 2022
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritisAlessandra Alongi, Gabriella Giancane, Roberta Naddei, et al.
Arthritis and Rheumatism|October 31, 2009
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage indexLisa G Rider, Peter A Lachenbruch, Jason B Monroe, et al.
Clinical and Translational Medicine|September 30, 2022
Extracellular vesicle-derived microRNAs as potential biomarkers in oligoarticular juvenile idiopathic arthritis patients: methodological challenges and new perspectivesFederica Raggi, Davide Cangelosi, Alessandro Consolaro, et al.
Pageof 35

Showing results (191-200 of 341) with videos related to

Sort By:
Pageof 35
Annals of the Rheumatic Diseases|December 19, 2013
Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity scoreAlessandro Consolaro, Nicolino Ruperto, Giulia Bracciolini, et al.
Annals of the Rheumatic Diseases|June 15, 2016
Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritisClaudia Bracaglia, Kathy de Graaf, Denise Pires Marafon, et al.
Journal of Pediatric Hematology/Oncology|February 24, 2021
Underlying CTLA4 Deficiency in a Patient With Juvenile Idiopathic Arthritis and Autoimmune Lymphoproliferative Syndrome Features Successfully Treated With Abatacept-A Case ReportMarta Mazzoni, Gianluca Dell'Orso, Alice Grossi, et al.
Arthritis and Rheumatism|November 13, 2002
Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositisMargherita Massa, Nick Costouros, Federica Mazzoli, et al.
Arthritis Research & Therapy|September 11, 2020
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trialsClara Malattia, Nicolino Ruperto, Silvia Pederzoli, et al.
Rheumatology (Oxford, England)|July 21, 2019
Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent feversRiccardo Papa, Marta Rusmini, Stefano Volpi, et al.
Rheumatology (Oxford, England)|August 15, 2019
Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent feversRiccardo Papa, Marta Rusmini, Stefano Volpi, et al.
RMD Open|March 8, 2022
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritisAlessandra Alongi, Gabriella Giancane, Roberta Naddei, et al.
Arthritis and Rheumatism|October 31, 2009
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage indexLisa G Rider, Peter A Lachenbruch, Jason B Monroe, et al.
Clinical and Translational Medicine|September 30, 2022
Extracellular vesicle-derived microRNAs as potential biomarkers in oligoarticular juvenile idiopathic arthritis patients: methodological challenges and new perspectivesFederica Raggi, Davide Cangelosi, Alessandro Consolaro, et al.
Pageof 35